Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Other Non-Current Liabilities: 2012-2025

Historic Other Non-Current Liabilities for ProPhase Labs (PRPH) over the last 5 years, with Sep 2025 value amounting to $2.0 million.

  • ProPhase Labs' Other Non-Current Liabilities changed negligibly% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that ProPhase Labs reported Other Non-Current Liabilities of $2.0 million as of Q3 2025, which was down 0.00% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, ProPhase Labs' Other Non-Current Liabilities peaked at $2.0 million during Q1 2023, and registered a low of $2.0 million during Q1 2023.
  • In the last 3 years, ProPhase Labs' Other Non-Current Liabilities had a median value of $2.0 million in 2025 and averaged $2.0 million.